Modified Laparoendoscopic Rendezvous for Secondary Choledocholithiasis: a Nonrandomized Controlled Clinical Study
Launched by SHENZHEN SECOND PEOPLE'S HOSPITAL · Sep 13, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment method called modified Laparoendoscopic Rendezvous (LERV) for patients with choledocholithiasis, which is a condition where stones are stuck in the common bile duct—a tube that carries bile from the liver to the intestine. The researchers want to find out how successful this modified technique is, especially in patients whose bile ducts are not enlarged (less than or equal to 10mm in diameter). They hope to determine if this method could become a standard treatment for those dealing with stones that have formed as a result of gallbladder stones.
To be eligible for this trial, participants should be between 18 and 85 years old, have a diagnosis of choledocholithiasis related to gallbladder stones, and must have good heart and lung function to tolerate the surgery. It's important to note that people with certain conditions, such as severe pancreatitis or large numbers of stones, will not be included. For those who join the trial, they can expect to undergo a combination of laparoscopic (minimally invasive) and endoscopic (using a flexible tube with a camera) procedures, all under general anesthesia. The study is currently recruiting participants, so if you or someone you know fits the criteria, it might be an opportunity to explore a potential new treatment option.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1、18 years ≤ age \<85 years 2、clinical diagnosis of choledocholithiasis secondary to cholecystolithiasis and middle choledocholithiasis (MCBD) diameter ≤10mm; The diameter of MCBD was based on MRCP measurements. If MRCP could not be performed, CT images were used as reference, and B-ultrasound measurements were used as the standard.
- • 3、 Good cardiopulmonary function, anesthesia evaluation tolerance under general anesthesia laparoscopic + endoscopic surgery.
- • -
- Exclusion Criteria:
- • 1、 Intrahepatic bile duct stones with indications for surgery, and need simultaneous surgery; 2、 Patients with choledocholithiasis \>2 cm or a large number of stones were difficult to remove; 3、 Patients with malignant hepatobiliary and pancreatic tumors or biliary tract malformations; 4、 Severe patients with severe pancreatitis and septic shock before operation; 5、Patients with previous gastric and duodenoscopic surgery history and interruption of gastroduodenal continuity; 6、 Severe partial stenosis of the upper gastrointestinal tract (from the oral cavity to the second duodenum), which is expected to be inaccessible to the duodenoscope.
- • -
About Shenzhen Second People's Hospital
Shenzhen Second People's Hospital is a leading healthcare institution located in Shenzhen, China, known for its commitment to advancing medical research and clinical innovation. As a prominent clinical trial sponsor, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experienced professionals to conduct high-quality research aimed at improving patient outcomes. The institution is dedicated to adhering to rigorous ethical standards and regulatory compliance while fostering collaborations with academic and industry partners to explore novel therapeutic interventions across various medical fields. Through its clinical trials, Shenzhen Second People's Hospital aims to contribute significantly to the global body of medical knowledge and enhance evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
Patients applied
Trial Officials
Zibing Fan, Attending physician
Study Chair
Shenzhen Second People's Hospital
Ganchen Sun, Nurse practitioner
Study Chair
Shenzhen Second People's Hospital
Yanan Bao, nurse-in-charge
Study Chair
Shenzhen Second People's Hospital
Xuelin Liu, Nurse practitioner
Study Chair
Shenzhen Second People's Hospital
Haoyuan Deng, Attending physician
Study Chair
Shenzhen Second People's Hospital
Yifan Zhang, Master's Degree student
Study Chair
Shenzhen Second People's Hospital
Yang Li, Nurse practitioner
Study Chair
Shenzhen Second People's Hospital
Haoran Ma, Nurse practitioner
Study Chair
Shenzhen Second People's Hospital
Naiyang Zhan, Attending physician
Study Chair
Shenzhen Second People's Hospital
Yiyuan Chen, Master's Degree student
Study Chair
Shenzhen Second People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials